SEC Comment Letter for Jaguar Health, Inc. (JAGX) (CIK 0001585608) (JAGX) — Jul 6, 2017
Jaguar Health, Inc. (JAGX) (CIK 0001585608)
Date: July 6, 2017 · CIK: 0001585608 · Accession: 0000000000-17-023663
AI Filing Summary & Sentiment
Reasoning
Letter
Mail Stop 4546 July 6, 2017 Lisa A. Conte Chief Executive Officer and President Jaguar Animal Health, Inc. 201 Mission Street, Suite 2375 San Francisco, California 94105
Re: Jaguar Animal Health, Inc. Form 10 -K for Fiscal Year Ended December 31, 2016 Filed February 15, 2017 File No. 001 -36714
Dear Ms. Conte :
We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff .
Sincerely,
/s/ Joseph McCann for
Show Raw Text
Mail Stop 4546 July 6, 2017 Lisa A. Conte Chief Executive Officer and President Jaguar Animal Health, Inc. 201 Mission Street, Suite 2375 San Francisco, California 94105 Re: Jaguar Animal Health, Inc. Form 10 -K for Fiscal Year Ended December 31, 2016 Filed February 15, 2017 File No. 001 -36714 Dear Ms. Conte : We have completed our review of your filing . We remind you that the company and its management are responsible for the accuracy and adequacy of the ir disclosure s, notwithstanding any review, comments, action or absence of action by the staff . Sincerely, /s/ Joseph McCann for Suzanne Hayes Assistant Director Office of Healthcare & Insurance cc: Michael Lee, Esq. Reed Smith LLP